Model‑based three‑dimensional texture analysis of contrast‑enhanced magnetic resonance imaging as a potential tool for preoperative prediction of microvascular invasion in hepatocellular carcinoma
The purpose of the present study was to investigate the value of contrast-enhanced magnetic resonance imaging (CE-MRI) texture analysis for preoperatively predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Accordingly, a retrospective study of 142 patients with pathologically...
Saved in:
Published in | Oncology letters Vol. 18; no. 1; pp. 720 - 732 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Greece
Spandidos Publications
01.07.2019
Spandidos Publications UK Ltd D.A. Spandidos |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The purpose of the present study was to investigate the value of contrast-enhanced magnetic resonance imaging (CE-MRI) texture analysis for preoperatively predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Accordingly, a retrospective study of 142 patients with pathologically confirmed HCC was performed. The patients were divided into two cohorts: The training cohort (n=99) and the validation cohort (n=43), including the MVI-positive group (n=53) and MVI-negative group (n=89). On the basis of three-dimensional texture analysis, 58 features were extracted from the preoperative CE-MR images of arterial-phase (AP) and portal-venous-phase (PP). The t-test or Kruskal-Wallis test, univariate logistic regression analysis and Pearson correlation were applied for feature reduction. Clinical-radiological features were also analyzed. Multivariate logistic regression analysis was used to build the texture model and combined model with clinical-radiological features. The MVI-predictive performance of the models was evaluated using receiver operating characteristic (ROC) analysis and presented using nomogram. Among the clinical features, a significant difference was found in maximum tumor diameter (P=0.002), tumor differentiation (P=0.026) and α-fetoprotein level (P=0.025) between the two groups in the training cohort. Four MR texture features in AP and five in PP images were identified through feature reduction. On ROC analysis, the AP texture model showed better diagnostic performance than did the PP model in the validation cohort, with an area under the curve (AUC) of 0.773 vs. 0.623, sensitivity of 0.750 vs. 0.500, and specificity of 0.815 vs. 0.926. Together with the clinical features, the combined model of AP improved the AUC, sensitivity and specificity to 0.810, 0.811 and 0.790, respectively, which was demonstrated in nomogram. To conclude, model-based texture analysis of CE-MRI could predict MVI in HCC preoperatively and noninvasively, and the AP image shows better predictive efficiency than PP image. The combined model of AP with clinical-radiological features could improve MVI prediction ability. |
---|---|
AbstractList | The purpose of the present study was to investigate the value of contrast-enhanced magnetic resonance imaging (CE-MRI) texture analysis for preoperatively predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Accordingly, a retrospective study of 142 patients with pathologically confirmed HCC was performed. The patients were divided into two cohorts: The training cohort (n=99) and the validation cohort (n=43), including the MVI-positive group (n=53) and MVI-negative group (n=89). On the basis of three-dimensional texture analysis, 58 features were extracted from the preoperative CE-MR images of arterial-phase (AP) and portal-venous-phase (PP). The t-test or Kruskal-Wallis test, univariate logistic regression analysis and Pearson correlation were applied for feature reduction. Clinical-radiological features were also analyzed. Multivariate logistic regression analysis was used to build the texture model and combined model with clinical-radiological features. The MVI-predictive performance of the models was evaluated using receiver operating characteristic (ROC) analysis and presented using nomogram. Among the clinical features, a significant difference was found in maximum tumor diameter (P=0.002), tumor differentiation (P=0.026) and α-fetoprotein level (P=0.025) between the two groups in the training cohort. Four MR texture features in AP and five in PP images were identified through feature reduction. On ROC analysis, the AP texture model showed better diagnostic performance than did the PP model in the validation cohort, with an area under the curve (AUC) of 0.773 vs. 0.623, sensitivity of 0.750 vs. 0.500, and specificity of 0.815 vs. 0.926. Together with the clinical features, the combined model of AP improved the AUC, sensitivity and specificity to 0.810, 0.811 and 0.790, respectively, which was demonstrated in nomogram. To conclude, model-based texture analysis of CE-MRI could predict MVI in HCC preoperatively and noninvasively, and the AP image shows better predictive efficiency than PP image. The combined model of AP with clinical-radiological features could improve MVI prediction ability. The purpose of the present study was to investigate the value of contrast-enhanced magnetic resonance imaging (CE-MRI) texture analysis for preoperatively predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Accordingly, a retrospective study of 142 patients with pathologically confirmed HCC was performed. The patients were divided into two cohorts: The training cohort (n=99) and the validation cohort (n=43), including the MVI-positive group (n=53) and MVI-negative group (n=89). On the basis of three-dimensional texture analysis, 58 features were extracted from the preoperative CE-MR images of arterial-phase (AP) and portal-venous-phase (PP). The t-test or Kruskal-Wallis test, univariate logistic regression analysis and Pearson correlation were applied for feature reduction. Clinical-radiological features were also analyzed. Multivariate logistic regression analysis was used to build the texture model and combined model with clinical-radiological features. The MVI-predictive performance of the models was evaluated using receiver operating characteristic (ROC) analysis and presented using nomogram. Among the clinical features, a significant difference was found in maximum tumor diameter (P=0.002), tumor differentiation (P=0.026) and α-fetoprotein level (P=0.025) between the two groups in the training cohort. Four MR texture features in AP and five in PP images were identified through feature reduction. On ROC analysis, the AP texture model showed better diagnostic performance than did the PP model in the validation cohort, with an area under the curve (AUC) of 0.773 vs. 0.623, sensitivity of 0.750 vs. 0.500, and specificity of 0.815 vs. 0.926. Together with the clinical features, the combined model of AP improved the AUC, sensitivity and specificity to 0.810, 0.811 and 0.790, respectively, which was demonstrated in nomogram. To conclude, model-based texture analysis of CE-MRI could predict MVI in HCC preoperatively and noninvasively, and the AP image shows better predictive efficiency than PP image. The combined model of AP with clinical-radiological features could improve MVI prediction ability.The purpose of the present study was to investigate the value of contrast-enhanced magnetic resonance imaging (CE-MRI) texture analysis for preoperatively predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Accordingly, a retrospective study of 142 patients with pathologically confirmed HCC was performed. The patients were divided into two cohorts: The training cohort (n=99) and the validation cohort (n=43), including the MVI-positive group (n=53) and MVI-negative group (n=89). On the basis of three-dimensional texture analysis, 58 features were extracted from the preoperative CE-MR images of arterial-phase (AP) and portal-venous-phase (PP). The t-test or Kruskal-Wallis test, univariate logistic regression analysis and Pearson correlation were applied for feature reduction. Clinical-radiological features were also analyzed. Multivariate logistic regression analysis was used to build the texture model and combined model with clinical-radiological features. The MVI-predictive performance of the models was evaluated using receiver operating characteristic (ROC) analysis and presented using nomogram. Among the clinical features, a significant difference was found in maximum tumor diameter (P=0.002), tumor differentiation (P=0.026) and α-fetoprotein level (P=0.025) between the two groups in the training cohort. Four MR texture features in AP and five in PP images were identified through feature reduction. On ROC analysis, the AP texture model showed better diagnostic performance than did the PP model in the validation cohort, with an area under the curve (AUC) of 0.773 vs. 0.623, sensitivity of 0.750 vs. 0.500, and specificity of 0.815 vs. 0.926. Together with the clinical features, the combined model of AP improved the AUC, sensitivity and specificity to 0.810, 0.811 and 0.790, respectively, which was demonstrated in nomogram. To conclude, model-based texture analysis of CE-MRI could predict MVI in HCC preoperatively and noninvasively, and the AP image shows better predictive efficiency than PP image. The combined model of AP with clinical-radiological features could improve MVI prediction ability. The purpose of the present study was to investigate the value of contrast-enhanced magnetic resonance imaging (CE-MRI) texture analysis for preoperatively predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Accordingly, a retrospective study of 142 patients with pathologically confirmed HCC was performed. The patients were divided into two cohorts: The training cohort (n=99) and the validation cohort (n=43), including the MVI-positive group (n=53) and MVI-negative group (n=89). On the basis of three-dimensional texture analysis, 58 features were extracted from the preoperative CE-MR images of arterial-phase (AP) and portal-venous-phase (PP). The t-test or Kruskal-Wallis test, univariate logistic regression analysis and Pearson correlation were applied for feature reduction. Clinical-radiological features were also analyzed. Multivariate logistic regression analysis was used to build the texture model and combined model with clinical-radiological features. The MVI-predictive performance of the models was evaluated using receiver operating characteristic (ROC) analysis and presented using nomogram. Among the clinical features, a significant difference was found in maximum tumor diameter (P=0.002), tumor differentiation (P=0.026) and a-fetoprotein level (P=0.025) between the two groups in the training cohort. Four MR texture features in AP and five in PP images were identified through feature reduction. On ROC analysis, the AP texture model showed better diagnostic performance than did the PP model in the validation cohort, with an area under the curve (AUC) of 0.773 vs. 0.623, sensitivity of 0.750 vs. 0.500, and specificity of 0.815 vs. 0.926. Together with the clinical features, the combined model of AP improved the AUC, sensitivity and specificity to 0.810, 0.811 and 0.790, respectively, which was demonstrated in nomogram. To conclude, model-based texture analysis of CE-MRI could predict MVI in HCC preoperatively and noninvasively, and the AP image shows better predictive efficiency than PP image. The combined model of AP with clinical-radiological features could improve MVI prediction ability. |
Audience | Academic |
Author | Zhao, Xin‑Ming Zhu, Yong‑Jian Feng, Bing Ma, Xiao‑Hong Wang, Li‑Ming Wang, Shuang Wu, Jiang‑Fen |
AuthorAffiliation | 2 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China 1 Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China 3 GE Healthcare Shanghai Co., Ltd., Shanghai 201203, P.R. China |
AuthorAffiliation_xml | – name: 3 GE Healthcare Shanghai Co., Ltd., Shanghai 201203, P.R. China – name: 2 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China – name: 1 Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China |
Author_xml | – sequence: 1 givenname: Yong‑Jian surname: Zhu fullname: Zhu, Yong‑Jian organization: Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China – sequence: 2 givenname: Bing surname: Feng fullname: Feng, Bing organization: Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China – sequence: 3 givenname: Shuang surname: Wang fullname: Wang, Shuang organization: Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China – sequence: 4 givenname: Li‑Ming surname: Wang fullname: Wang, Li‑Ming organization: Department of Hepatobiliary Surgery,, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China – sequence: 5 givenname: Jiang‑Fen surname: Wu fullname: Wu, Jiang‑Fen organization: GE Healthcare Shanghai Co., Ltd., Shanghai 201203, P.R. China – sequence: 6 givenname: Xiao‑Hong surname: Ma fullname: Ma, Xiao‑Hong organization: Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China – sequence: 7 givenname: Xin‑Ming surname: Zhao fullname: Zhao, Xin‑Ming organization: Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31289547$$D View this record in MEDLINE/PubMed |
BookMark | eNptUstuFDEQHKEgEkKOXJElJMRll_E87QtSFPGSgrjA2er19Ow48tqL7VklN36B3-Iz-BLaeZFEmTmMu7uqetxdz4s95x0WxUteLmshq3feLquSyyUv6148KQ54L6sFL0W1d3vum_3iKMazkp6240J0z4r9mldCtk1_UPz56ge0f3_9XkHEgaUpIFI0mA26aLwDyxKepzkgAwouoonMj0x7lwLERFB0EzhN3A2sHSajWcBIRMoxQznj1gwiA7b1CV0yWdF7y0Yf2Dag32KAZHaYg8HoRE1zh43Rwe8g6tlCYMbRMVeMYxNuIXmN1l6WNARtnN_Ai-LpCDbi0fX3sPjx8cP3k8-L02-fvpwcny50y-u0EF0jKt5DJ0feaDm2uitXqxUA6BZarTuhaYAwyFoTbuAoOPa66sZaQCV1Ux8W7690t_Nqg4PGPAqrtoFuGy6UB6PuV5yZ1NrvVNc2nZQdCby9Fgj-54wxqY2J-T7g0M9RVVVLu2nrLvd6_QB65udAi8iouhFCNn39H7UGi8q40VNfnUXVcSukKEtZZq3lIyh6B6Rhk7FGQ_l7hDd3CBOCTVP0ds4riveBr-5O5HYUNzYjQH0FoJ3GGHBU2iTIOvQLxipequxn5a3KflaXfibW4gHrRvhx_D9MpP6q |
CitedBy_id | crossref_primary_10_20517_ais_2024_09 crossref_primary_10_3389_fonc_2021_633596 crossref_primary_10_3389_fonc_2022_960944 crossref_primary_10_3748_wjg_v30_i4_381 crossref_primary_10_61186_rabms_11_1_19 crossref_primary_10_2147_JHC_S464916 crossref_primary_10_35711_aimi_v3_i4_87 crossref_primary_10_3389_fmed_2022_819670 crossref_primary_10_3389_fonc_2022_831996 crossref_primary_10_3389_fonc_2022_853336 crossref_primary_10_2147_CMAR_S245475 crossref_primary_10_1007_s42058_024_00146_z crossref_primary_10_31083_j_jmcm_2021_01_801 crossref_primary_10_2174_0115734056256824231204073534 crossref_primary_10_3389_fonc_2021_698373 crossref_primary_10_4251_wjgo_v17_i1_96439 crossref_primary_10_1159_000513704 crossref_primary_10_4251_wjgo_v16_i4_1309 crossref_primary_10_3389_fonc_2020_00887 |
Cites_doi | 10.1148/radiol.2017170143 10.1016/S0140-6736(11)61347-0 10.1016/j.jhep.2017.04.024 10.1016/j.acra.2006.04.017 10.1007/s00261-014-0256-0 10.3322/caac.21262 10.1016/j.athoracsur.2018.02.026 10.1016/j.crad.2004.07.008 10.1111/jgh.12358 10.1007/s00261-017-1207-3 10.1001/jamasurg.2015.4257 10.1186/s12880-017-0212-x 10.1007/s00261-017-1072-0 10.2214/AJR.13.10595 10.2214/AJR.15.15864 10.1002/lt.20472 10.1007/s10147-017-1189-8 10.2214/AJR.17.18417 10.1007/s00330-017-4881-1 10.1097/01.sla.0000171307.37401.db 10.1016/j.cld.2015.01.001 10.1002/jso.21631 10.1053/j.gastro.2009.06.003 10.1148/radiol.2291010898 10.1016/j.ejrad.2017.02.043 10.1097/SLA.0b013e31821ad884 10.1016/j.ejrad.2012.10.023 10.1111/hepr.12196 10.1016/j.acra.2017.05.006 10.1186/1471-2407-14-38 10.1111/liv.12459 10.1245/s10434-012-2513-1 10.1259/bjr.20160642 10.1016/j.ejso.2013.04.003 10.3322/caac.21338 10.1097/SLA.0000000000001556 10.1007/s00330-016-4540-y 10.2214/AJR.15.15451 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 Spandidos Publications Copyright Spandidos Publications UK Ltd. 2019 Copyright: © Zhu et al. 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 Spandidos Publications – notice: Copyright Spandidos Publications UK Ltd. 2019 – notice: Copyright: © Zhu et al. 2019 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. M0S PHGZM PHGZT PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.3892/ol.2019.10378 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database (Proquest) ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) British Nursing Index with Full Text ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection ProQuest One Health & Nursing Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central (New) ProQuest One Academic ProQuest Central (Alumni) ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1792-1082 |
EndPage | 732 |
ExternalDocumentID | PMC6546996 A589800904 31289547 10_3892_ol_2019_10378 |
Genre | Journal Article |
GeographicLocations | Taiwan China |
GeographicLocations_xml | – name: Taiwan – name: China |
GroupedDBID | --- 0R~ 53G 7X7 8FI 8FJ AAKDD AAYXX ABDBF ABJNI ABUWG ACGFS ACUHS ADBBV AENEX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BENPR BNQBC BPHCQ BVXVI C45 CCPQU CITATION EBD EBS EJD ESX F5P FYUFA H13 HMCUK HUR HZ~ IAO IHR IHW IPNFZ ITC O9- OK1 OVD PHGZM PHGZT PQQKQ PROAC RIG RPM TEORI UKHRP W2D NPM PMFND 3V. 7XB 8FK K9. PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c513t-8648217a69f14c9f5c60bbbaaac5a5cc68c082ad93c821d1e81e7c26f38a29c43 |
IEDL.DBID | 7X7 |
ISSN | 1792-1074 |
IngestDate | Thu Aug 21 18:33:30 EDT 2025 Fri Jul 11 04:24:29 EDT 2025 Fri Jul 25 20:02:25 EDT 2025 Tue Jun 17 21:30:38 EDT 2025 Tue Jun 10 20:35:17 EDT 2025 Thu May 22 21:13:09 EDT 2025 Thu Apr 03 07:04:15 EDT 2025 Tue Jul 01 01:58:47 EDT 2025 Thu Apr 24 23:03:03 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 1 |
Keywords | prediction magnetic resonance imaging hepatocellular carcinoma microvascular invasion texture analysis |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c513t-8648217a69f14c9f5c60bbbaaac5a5cc68c082ad93c821d1e81e7c26f38a29c43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Contributed equally |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC6546996 |
PMID | 31289547 |
PQID | 2234889473 |
PQPubID | 2044954 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6546996 proquest_miscellaneous_2255475364 proquest_journals_2234889473 gale_infotracmisc_A589800904 gale_infotracacademiconefile_A589800904 gale_healthsolutions_A589800904 pubmed_primary_31289547 crossref_citationtrail_10_3892_ol_2019_10378 crossref_primary_10_3892_ol_2019_10378 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-07-01 |
PublicationDateYYYYMMDD | 2019-07-01 |
PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Greece |
PublicationPlace_xml | – name: Greece – name: Athens |
PublicationTitle | Oncology letters |
PublicationTitleAlternate | Oncol Lett |
PublicationYear | 2019 |
Publisher | Spandidos Publications Spandidos Publications UK Ltd D.A. Spandidos |
Publisher_xml | – name: Spandidos Publications – name: Spandidos Publications UK Ltd – name: D.A. Spandidos |
References | Scalco (key20200714090717_b16-ol-0-0-10378) 2017; 90 McGlynn (key20200714090717_b1-ol-0-0-10378) 2015; 19 Kim (key20200714090717_b27-ol-0-0-10378) 2010; 57 Lee (key20200714090717_b12-ol-0-0-10378) 2017; 67 Liu (key20200714090717_b33-ol-0-0-10378) 2017; 27 Lei (key20200714090717_b30-ol-0-0-10378) 2016; 151 Rodríguez-Perálvarez (key20200714090717_b8-ol-0-0-10378) 2013; 20 Pawlik (key20200714090717_b26-ol-0-0-10378) 2005; 11 Ahn (key20200714090717_b14-ol-0-0-10378) 2015; 40 Imura (key20200714090717_b39-ol-0-0-10378) 2018; 23 Forner (key20200714090717_b5-ol-0-0-10378) 2012; 379 Castellano (key20200714090717_b15-ol-0-0-10378) 2004; 59 Kaibori (key20200714090717_b28-ol-0-0-10378) 2010; 102 Ng (key20200714090717_b37-ol-0-0-10378) 2013; 82 Xu (key20200714090717_b38-ol-0-0-10378) 2006; 13 Chen (key20200714090717_b3-ol-0-0-10378) 2016; 66 Li (key20200714090717_b22-ol-0-0-10378) 2017; 17 Zhao (key20200714090717_b35-ol-0-0-10378) 2013; 39 Gu (key20200714090717_b24-ol-0-0-10378) 2018; 106 Hirokawa (key20200714090717_b10-ol-0-0-10378) 2014; 44 Du (key20200714090717_b7-ol-0-0-10378) 2014; 14 Roayaie (key20200714090717_b9-ol-0-0-10378) 2009; 137 Lim (key20200714090717_b6-ol-0-0-10378) 2011; 254 Chou (key20200714090717_b11-ol-0-0-10378) 2014; 203 Obuchowski (key20200714090717_b25-ol-0-0-10378) 2003; 229 Kloth (key20200714090717_b23-ol-0-0-10378) 2017; 24 Bashir (key20200714090717_b18-ol-0-0-10378) 2016; 207 Hasegawa (key20200714090717_b36-ol-0-0-10378) 2005; 242 Torre (key20200714090717_b2-ol-0-0-10378) 2015; 65 Dhir (key20200714090717_b4-ol-0-0-10378) 2016; 263 Chamming's (key20200714090717_b20-ol-0-0-10378) 2018; 286 Giganti (key20200714090717_b31-ol-0-0-10378) 2017; 90 Zhou (key20200714090717_b32-ol-0-0-10378) 2017; 42 Giganti (key20200714090717_b19-ol-0-0-10378) 2017; 27 Nakajo (key20200714090717_b21-ol-0-0-10378) 2017; 42 Xu (key20200714090717_b13-ol-0-0-10378) 2014; 29 Lubner (key20200714090717_b34-ol-0-0-10378) 2016; 207 Shirabe (key20200714090717_b29-ol-0-0-10378) 2014; 34 Canellas (key20200714090717_b17-ol-0-0-10378) 2018; 210 |
References_xml | – volume: 286 start-page: 412 year: 2018 ident: key20200714090717_b20-ol-0-0-10378 article-title: Features from computerized texture analysis of breast cancers at pretreatment MR imaging are associated with response to neoadjuvant chemotherapy publication-title: Radiology doi: 10.1148/radiol.2017170143 – volume: 379 start-page: 1245 year: 2012 ident: key20200714090717_b5-ol-0-0-10378 article-title: Hepatocellular carcinoma publication-title: Lancet doi: 10.1016/S0140-6736(11)61347-0 – volume: 67 start-page: 526 year: 2017 ident: key20200714090717_b12-ol-0-0-10378 article-title: Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma publication-title: J Hepatol doi: 10.1016/j.jhep.2017.04.024 – volume: 13 start-page: 969 year: 2006 ident: key20200714090717_b38-ol-0-0-10378 article-title: Computer-aided classification of interstitial lung diseases via MDCT: 3D adaptive multiple feature method (3D AMFM) publication-title: Acad Radiol doi: 10.1016/j.acra.2006.04.017 – volume: 40 start-page: 843 year: 2015 ident: key20200714090717_b14-ol-0-0-10378 article-title: Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT publication-title: Abdom Imaging doi: 10.1007/s00261-014-0256-0 – volume: 65 start-page: 87 year: 2015 ident: key20200714090717_b2-ol-0-0-10378 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J Clin doi: 10.3322/caac.21262 – volume: 106 start-page: 214 year: 2018 ident: key20200714090717_b24-ol-0-0-10378 article-title: A texture analysis-based prediction model for lymph node metastasis in stage IA lung adenocarcinoma publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2018.02.026 – volume: 59 start-page: 1061 year: 2004 ident: key20200714090717_b15-ol-0-0-10378 article-title: Texture analysis of medical images publication-title: Clin Radiol doi: 10.1016/j.crad.2004.07.008 – volume: 29 start-page: 330 year: 2014 ident: key20200714090717_b13-ol-0-0-10378 article-title: Microvascular invasion in small hepatocellular carcinoma: Is it predictable with preoperative diffusion-weighted imaging? publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.12358 – volume: 42 start-page: 2882 year: 2017 ident: key20200714090717_b21-ol-0-0-10378 article-title: Texture analysis of FDG PET/CT for differentiating between FDG-avid benign and metastatic adrenal tumors: Efficacy of combining SUV and texture parameters publication-title: Abdom Radiol (NY) doi: 10.1007/s00261-017-1207-3 – volume: 151 start-page: 356 year: 2016 ident: key20200714090717_b30-ol-0-0-10378 article-title: Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria publication-title: JAMA Surg doi: 10.1001/jamasurg.2015.4257 – volume: 17 start-page: 42 year: 2017 ident: key20200714090717_b22-ol-0-0-10378 article-title: Texture-based classification of different single liver lesion based on SPAIR T2W MRI images publication-title: BMC Med Imaging doi: 10.1186/s12880-017-0212-x – volume: 42 start-page: 1695 year: 2017 ident: key20200714090717_b32-ol-0-0-10378 article-title: CT-based radiomics signature: A potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma publication-title: Abdom Radiol (NY) doi: 10.1007/s00261-017-1072-0 – volume: 203 start-page: W253 year: 2014 ident: key20200714090717_b11-ol-0-0-10378 article-title: Prediction of microvascular invasion of hepatocellular carcinoma: Preoperative CT and histopathologic correlation publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.13.10595 – volume: 207 start-page: 534 year: 2016 ident: key20200714090717_b18-ol-0-0-10378 article-title: Imaging heterogeneity in lung cancer: Techniques, applications, and challenges publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.15.15864 – volume: 11 start-page: 1086 year: 2005 ident: key20200714090717_b26-ol-0-0-10378 article-title: Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma publication-title: Liver Transpl doi: 10.1002/lt.20472 – volume: 23 start-page: 98 year: 2018 ident: key20200714090717_b39-ol-0-0-10378 article-title: Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria publication-title: Int J Clin Oncol doi: 10.1007/s10147-017-1189-8 – volume: 210 start-page: 341 year: 2018 ident: key20200714090717_b17-ol-0-0-10378 article-title: Prediction of pancreatic neuroendocrine tumor grade based on CT features and texture analysis publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.17.18417 – volume: 27 start-page: 4951 year: 2017 ident: key20200714090717_b33-ol-0-0-10378 article-title: Application of CT texture analysis in predicting histopathological characteristics of gastric cancers publication-title: Eur Radiol doi: 10.1007/s00330-017-4881-1 – volume: 242 start-page: 252 year: 2005 ident: key20200714090717_b36-ol-0-0-10378 article-title: Prognostic impact of anatomic resection for hepatocellular carcinoma publication-title: Ann Surg doi: 10.1097/01.sla.0000171307.37401.db – volume: 19 start-page: 223 year: 2015 ident: key20200714090717_b1-ol-0-0-10378 article-title: Global epidemiology of hepatocellular carcinoma: An emphasis on demographic and regional variability publication-title: Clin Liver Dis doi: 10.1016/j.cld.2015.01.001 – volume: 102 start-page: 462 year: 2010 ident: key20200714090717_b28-ol-0-0-10378 article-title: Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma publication-title: J Surg Oncol doi: 10.1002/jso.21631 – volume: 137 start-page: 850 year: 2009 ident: key20200714090717_b9-ol-0-0-10378 article-title: A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.06.003 – volume: 229 start-page: 3 year: 2003 ident: key20200714090717_b25-ol-0-0-10378 article-title: Receiver operating characteristic curves and their use in radiology publication-title: Radiology doi: 10.1148/radiol.2291010898 – volume: 90 start-page: 129 year: 2017 ident: key20200714090717_b31-ol-0-0-10378 article-title: Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2017.02.043 – volume: 254 start-page: 108 year: 2011 ident: key20200714090717_b6-ol-0-0-10378 article-title: Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria publication-title: Ann Surg doi: 10.1097/SLA.0b013e31821ad884 – volume: 82 start-page: 342 year: 2013 ident: key20200714090717_b37-ol-0-0-10378 article-title: Assessment of tumor heterogeneity by CT texture analysis: Can the largest cross-sectional area be used as an alternative to whole tumor analysis? publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2012.10.023 – volume: 57 start-page: 121 year: 2010 ident: key20200714090717_b27-ol-0-0-10378 article-title: Tumor size predicts the biological behavior and influence of operative modalities in hepatocellular carcinoma publication-title: Hepatogastroenterology – volume: 44 start-page: 846 year: 2014 ident: key20200714090717_b10-ol-0-0-10378 article-title: Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma publication-title: Hepatol Res doi: 10.1111/hepr.12196 – volume: 24 start-page: 1352 year: 2017 ident: key20200714090717_b23-ol-0-0-10378 article-title: Evaluation of texture analysis parameter for response prediction in patients with hepatocellular carcinoma undergoing drug-eluting bead transarterial chemoembolization (DEB-TACE) using biphasic contrast-enhanced CT image data: Correlation with liver perfusion CT publication-title: Acad Radiol doi: 10.1016/j.acra.2017.05.006 – volume: 14 start-page: 38 year: 2014 ident: key20200714090717_b7-ol-0-0-10378 article-title: Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma publication-title: BMC Cancer doi: 10.1186/1471-2407-14-38 – volume: 34 start-page: 937 year: 2014 ident: key20200714090717_b29-ol-0-0-10378 article-title: New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma publication-title: Liver Int doi: 10.1111/liv.12459 – volume: 20 start-page: 325 year: 2013 ident: key20200714090717_b8-ol-0-0-10378 article-title: A systematic review of microvascular invasion in hepatocellular carcinoma: Diagnostic and prognostic variability publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2513-1 – volume: 90 start-page: 20160642 year: 2017 ident: key20200714090717_b16-ol-0-0-10378 article-title: Texture analysis of medical images for radiotherapy applications publication-title: Br J Radiol doi: 10.1259/bjr.20160642 – volume: 39 start-page: 858 year: 2013 ident: key20200714090717_b35-ol-0-0-10378 article-title: Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2013.04.003 – volume: 66 start-page: 115 year: 2016 ident: key20200714090717_b3-ol-0-0-10378 article-title: Cancer statistics in China, 2015 publication-title: CA Cancer J Clin doi: 10.3322/caac.21338 – volume: 263 start-page: 1112 year: 2016 ident: key20200714090717_b4-ol-0-0-10378 article-title: A review and update of treatment options and controversies in the management of hepatocellular carcinoma publication-title: Ann Surg doi: 10.1097/SLA.0000000000001556 – volume: 27 start-page: 1831 year: 2017 ident: key20200714090717_b19-ol-0-0-10378 article-title: Gastric cancer: Texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker publication-title: Eur Radiol doi: 10.1007/s00330-016-4540-y – volume: 207 start-page: 96 year: 2016 ident: key20200714090717_b34-ol-0-0-10378 article-title: CT textural analysis of large primary renal cell carcinomas: Pretreatment tumor heterogeneity correlates with histologic findings and clinical outcomes publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.15.15451 |
SSID | ssj0000561886 |
Score | 2.3217604 |
Snippet | The purpose of the present study was to investigate the value of contrast-enhanced magnetic resonance imaging (CE-MRI) texture analysis for preoperatively... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 720 |
SubjectTerms | Carcinoma Diagnostic imaging Hepatitis Hepatocellular carcinoma Liver cancer Medical imaging Medical prognosis Mortality NMR Nomograms Nuclear magnetic resonance Oncology Patients Regression analysis Studies |
Title | Model‑based three‑dimensional texture analysis of contrast‑enhanced magnetic resonance imaging as a potential tool for preoperative prediction of microvascular invasion in hepatocellular carcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31289547 https://www.proquest.com/docview/2234889473 https://www.proquest.com/docview/2255475364 https://pubmed.ncbi.nlm.nih.gov/PMC6546996 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgkxAviN8ExjASghesNXHi2E9ooE0T0iaEmNS3yHactVJrhzb9D_nDuHPSsCDBWytfXKd39p3t774j5J01jeLCaVZrPLpRwjElZMNMWfPUKJfVNeYOX16Ji-v867yYDwdu2wFWuV8T40JdB4tn5CfgxsDWVF7yT-1PhlWj8HZ1KKFxlxwidRladTkvxzMWjI5lLPYIZpcxxB72NJvgpbOTgDcPqYpp53Lilv5enG95pyly8pYrOn9IHgwxJD3tlf6I3HH-Mbl3OdySPyG_sMDZiqGDqmkHynKsRhL_noCDItZjt3FUD3wkNDQ0Itb1tmPOLyImgK71jccERwr78YCsHI4u17GkEdVbqmkbOgQaYX8hrCjEvrTduNC6nkocv9TLmDSB_a8R97dHvdKlh4_YsvR0Af6wC3h_EJss1jbyYa2fkuvzsx9fLthQrYHZIuUdkyKXsL_RQjVpblVTWDEzxmitbaELa4W0EG7oWnELcnXqZOpKm4mGS50pm_Nn5MAH714QWhbCmUaaPFezXCOqK4MnXK74TJmy4Qn5uFdWZQcqc6yosapgS4O6rcKqQt1WUbcJeT-Ktz2Hx78E36Dmqz4FdZz71WkhFQTWMJiEfIgSOPvhF60ekhhg3MijNZE8mkjCrLXT5r11VcOqsa3-2HhC3o7N-CQi4bwLO5SBABD2mAK6eN4b4_hSHIINBa0JKSdmOgogl_i0xS8XkVMcc9pg6_vy_8N6Re7jv9XDlY_IQbfZudcQlHXmOM68Y3L4-ezq2_ffAV49cw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4k2gUCPxuGB183LiA0IVUG1pt6dW2luwHYeNtBuH3awQf4pfwQ9jxnnQIMGtt1154nV2xvOwv5kh5KVWhQi5kSyXeHQjuGGCpwVTSR76SpggzzF3eHbGpxfR53k83yE_-1wYhFX2OtEp6txqPCM_ADMGsiaiJHxff2PYNQpvV_sWGq1YnJgf3yFk27w7_gj8fRUER5_OP0xZ11WA6dgPG5byKAU_XHJR-JEWRaz5RCklpdSxjLXmqQazKHMRaqDLfZP6JtEBL8JUBkJHIcx7jVwHwzvBYC-ZJ8OZDnrjqWsuCWIeMMQ6tmU9wSsIDizedPjCpbmnIzP4tzG4ZA3HSM1Lpu_oDrnd-az0sBWyu2THVPfIjVl3K3-f_MKGakuGBjGnDQiHYTk2DWgLflDElmzXhsqu_gm1BXUIeblpmKkWDoNAV_JrhQmVFOJ_i1VADC1XroUSlRsqaW0bBDbhfNYuKfjatF4bW5u2dDl-yUuXpIHzrxBn2KNsaVnBRxwpK7oA-9tYvK9wQxp7KVV2JR-Qiyvh40OyW9nKPCY0iblRRaqiSEwiiSiyAJ4wkQgnQiVF6JG3PbMy3ZVOxw4eywxCKORtZpcZ8jZzvPXI64G8bmuG_ItwHzmftSmvg67JDuNUgCMPi_HIG0eB2gZ-UcsuaQLWjXW7RpR7I0rQEno83EtX1mmpTfZnT3nkxTCMTyLyrjJ2izTgcEJMy2GKR60wDi8VgnMjYNQjyUhMBwKsXT4eqcqFq2GOOXQQaj_5_7L2yc3p-ew0Oz0-O3lKbuE_10Kl98hus96aZ-AQNuq524WUfLnqbf8bhsR5MA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJ028IL4JDGYkPl6w2nw58QNCg63aGKsmxKS9ZY7j0EhtHNpUiH-NZ_4w7pwPFiR421vbuzhp7uy7s393R8gLlebC51qyTOLWjeCaCR7nLI0y302F9rIMc4dPZ_zoPPh4EV5skZ9dLgzCKrs10S7UmVG4Rz4GMwa6JoLIH-ctLOLsYPqu-sawgxSetHbtNBoVOdE_vkP4tn57fACyful508MvH45Y22GAqdD1axbzIAafXHKRu4ESeaj4JE1TKaUKZagUjxWYSJkJXwFf5urY1ZHyeO7H0hMq8GHcG2Q7wqhoRLbfH87OPvc7POibx7bVJCi9xxD52BT5BB_BGxs893CFTXqPB0bxb9NwxTYOcZtXDOH0NrnVerB0v1G5O2RLl3fJzml7Rn-P_ML2aguG5jGjNaiKZhm2EGjKf1B8pZuVprKthkJNTi1eXq5rpsu5RSTQpfxaYnolXWmMFeA3WixtQyUq11TSytQIc8LxjFlQ8LxptdKm0k0hc_ySFTZlA8dfIuqww9zSooSPSClKOgdrXBs8vbAkhZ2VSrOU98n5tUjyARmVptSPCI1CrtM8ToNATAKJmDIPrtCB8CcijXLfIW86YSWqLaSO_TwWCQRUKNvELBKUbWJl65BXPXvVVBD5F-MeSj5pEmD7lSfZD2MBbj08jENeWw5ce-COSrYpFPDcWMVrwLk74IQ1Qw3JnXYl7Zq1Tv7MMIc878l4JeLwSm02yAPuJ0S4HIZ42Chj_6d8cHUEUB0SDdS0Z8BK5kNKWcxtRXPMqIPA-_H_H2uP7MCUTz4dz06ekJv44hrc9C4Z1auNfgreYZ0-a6chJZfXPfN_A0Jmfss |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Model-based+three-dimensional+texture+analysis+of+contrast-enhanced+magnetic+resonance+imaging+as+a+potential+tool+for+preoperative+prediction+of+microvascular+invasion+in+hepatocellular+carcinoma&rft.jtitle=Oncology+letters&rft.au=Zhu%2C+Yong-Jian&rft.au=Feng%2C+Bing&rft.au=Wang%2C+Shuang&rft.au=Wang%2C+Li-Ming&rft.date=2019-07-01&rft.pub=D.A.+Spandidos&rft.issn=1792-1074&rft.eissn=1792-1082&rft.volume=18&rft.issue=1&rft.spage=720&rft.epage=732&rft_id=info:doi/10.3892%2Fol.2019.10378&rft_id=info%3Apmid%2F31289547&rft.externalDocID=PMC6546996 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-1074&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-1074&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-1074&client=summon |